SARS COVID-19阳性状态对创伤患者静脉血栓栓塞和肺栓塞发生率的影响
该研究回顾了2020年4月至11月期间入住创伤外科≥48小时的成人患者,按COVID-19状态分组,比较住院期间VTE药物预防方案、血栓并发症、ICU住院时间、总住院时间和死亡率。共纳入2907例患者,COVID-19阳性组110例,阴性组2797例。阳性组VTE发生5例(4.55%),阴性组60例(2.15%),两组间无显著差异,VTE类型也无差异。阳性组启动药物预防的时间更长(P=0.0012),死亡率更高(P=0.009,10.91%),中位ICU住院时间(P=0.0012)和总住院时间(P<0.001)均更长。结论认为COVID-19阳性创伤患者VTE并发症未增加,但住院时间和死亡率增加,可能主要与基础COVID-19感染有关。
要点
- COVID-19阳性创伤患者VTE发生率5例(4.55%) vs 阴性患者60例(2.15%),两组间无显著差异。
- COVID-19阳性组启动VTE药物预防的时间显著长于阴性组(P=0.0012)。
- COVID-19阳性组死亡率10.91%,显著高于阴性组(P=0.009)。
- COVID-19阳性组中位ICU住院时间(P=0.0012)和总住院时间(P<0.001)均显著长于阴性组。
- 两组在是否接受VTE药物预防及预防类型上无差异。
适用人群与场景
- 2020年4月至11月入住创伤外科的成人患者(≥18岁),住院时间至少48小时。
研究设计与关键结果
- 研究类型:回顾性综述(reviewed all adult patients),纳入2907例创伤患者,COVID-19阳性组110例,阴性组2797例。
- VTE(深静脉血栓、肺栓塞、心肌梗死、脑血管意外)发生率:阳性组5例(4.55%) vs 阴性组60例(2.15%),两组间无显著差异,VTE类型也无差异。
- 两组接受VTE药物预防或预防类型无差异,但阳性组启动时间更长(P=0.0012)。
- 死亡率:阳性组10.91%,显著高于阴性组(P=0.009)。
- 中位ICU住院时间阳性组更长(P=0.0012),总住院时间阳性组更长(P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性研究(reviewed all adult patients admitted to the Trauma Service)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为COVID-19阳性创伤患者ICU住院时间、总住院时间和死亡率增加可能由多因素导致,但主要与基础COVID-19感染相关。
- 研究显示COVID-19阳性创伤患者VTE并发症未增加,但启动药物预防的时间更长。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction : COVID-19-induced coagulopathy (CIC) can increase the risk of thromboembolism without underlying clotting disorders, even when compared with other respiratory viruses. Trauma has a known association with hypercoagulability. Trauma patients with concurrent COVID-19 infection potentially have an even greater risk of thrombotic events. The purpose of this study was to evaluate venous thromboembolism (VTE) rates in trauma patients with COVID-19. Methods : This study reviewed all adult patients (≥18 years of age) admitted to the Trauma Service from April through November 2020 for a minimum of 48 hours. Patients were grouped based off COVID-19 status and compared for inpatient VTE chemoprophylaxis regimen, thrombotic complications defined as deep vein thrombosis, pulmonary embolism, myocardial infarction, and cerebrovascular accident, intensive care unit (ICU) length of stay, hospital length of stay, and mortality. Results : A total of 2,907 patients were reviewed and grouped into COVID-19-positive (n = 110) and COVID-19-negative (n = 2,797) groups. There was no difference in terms of receiving deep vein thrombosis chemoprophylaxis or type, but a longer time to initiation in the positive group ( P = 0.0012). VTE occurred in 5 (4.55%) positive and 60 (2.15%) negative patients without a significant difference between the groups, as well as no difference in type of VTE observed. Mortality was higher ( P = 0.009) in the positive group (10.91%). Positive patients had longer median ICU LOS ( P = 0.0012) and total LOS ( P < 0.001). Conclusion : There were no increased rates of VTE complications between COVID-19-positive and -negative trauma patients, despite a longer time to initiation of chemoprophylaxis in the COVID-19-positive group. COVID-19-positive patients had increased ICU LOS, total LOS, and mortality, which are likely due to multifactorial causes but primarily related to their underlying COVID-19 infection.
参考来源
- Kenney CL, Nelson AR, Fahey RA, et al. EFFECTS OF SARS COVID-19 POSITIVITY STATUS ON VENOUS THROMBOSIS AND PULMONARY EMBOLISM RATES IN TRAUMA PATIENTS. Shock. 2023. PMID: 36809212. doi:10.1097/SHK.0000000000002097
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。